| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |